Spots Global Cancer Trial Database for urothelial cis of bladder
Every month we try and update this database with for urothelial cis of bladder cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refactory Urothelial Carcinoma in Situ of the Bladder | NCT02901548 | Carcinoma in Si... Bladder Cancer | Durvalumab Cystoscopy with... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute |